Generic pharmaceuticals has become big business in recent years, as the drug industry has ricocheted down a series of patent cliffs over the last decade. You'd think it would be triples all round for investors; but in the US, publicly listed generics companies have actually seen their market capitalisation drop 57 percent since January 2016. Robert Wessman, founder of Alvogen, explains that customer consolidation and over-leveraging to acquire assets has changed the industry permanently. Watch our other interviews with the Alvogen chairman and CEO, where he discusses the company's origins on a restaurant napkin, and his vision of leadership.
For a full transcript visit: https://www.worldfinance.com/videos/alvogen-founder-generic-drug-price-wars-will-drive-consolidation
For more World Finance videos go to https://www.worldfinance.com/videos/
Community pharmacists are the health professionals most accessible to the public. They supply medicines in accordance with a prescription or, when legally permitted, sell them without a prescription. In addition to ensuring an accurate supply of appropriate products, their professional activities also cover counselling of patients at the time of dispensing of prescription and non-prescription drugs, drug information to health professionals, patients and the general public, and participation in health-promotion programmes. They maintain links with other health professionals in primary health care.